CWBHF (Charlottes Web Holdings) ROE %: 0.00% (As of Mar. 2026)


CWBHF Charlottes Web Holdings Inc CWBHF
32 GF Score
Price $0.33
GF Value $0.13
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Charlottes Web Holdings ROE %?

Charlottes Web Holdings CWBHF +2.19% 32 ROE % is 0.00% as of Mar. 2026. GuruFocus rates CWBHF with a GF Score™ of 32/100 and a GF Value™ of $0.13 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 935 Drug Manufacturers companies, Charlottes Web Holdings ranks worse than 99.47% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Charlottes Web Holdings's annualized net income for the quarter that ended in Mar. 2026 was $-52.45 Mil. Charlottes Web Holdings's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $-8.54 Mil. Therefore, Charlottes Web Holdings's annualized ROE % for the quarter that ended in Mar. 2026 was N/A%.

The historical rank and industry rank for Charlottes Web Holdings's ROE % or its related term are showing as below:

CWBHF' s ROE % Range Over the Past 10 Years
Min: -630.12   Med: -25.2   Max: 85.17
Current: -630.12

During the past 10 years, Charlottes Web Holdings's highest ROE % was 85.17%. The lowest was -630.12%. And the median was -25.20%.

CWBHF's ROE % is ranked worse than
99.47% of 935 companies
in the Drug Manufacturers industry
Industry Median: 6 vs CWBHF: -630.12

Charlottes Web Holdings  (OTCPK:CWBHF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-52.448/-8.54
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-52.448 / 44.636)*(44.636 / 72.98)*(72.98 / -8.54)
=Net Margin %*Asset Turnover*Equity Multiplier
=-117.5 %*0.6116*N/A
=ROA %*Equity Multiplier
=-71.86 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-52.448/-8.54
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-52.448 / -52.46) * (-52.46 / -17.296) * (-17.296 / 44.636) * (44.636 / 72.98) * (72.98 / -8.54)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9998 * 3.0331 * -38.75 % * 0.6116 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Charlottes Web Holdings ROE % Related Terms


Charlottes Web Holdings ROE % Historical Data

* Premium members only.

The historical data trend for Charlottes Web Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charlottes Web Holdings ROE % Chart

Charlottes Web Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -71.60 -57.05 -35.77 -72.23 -237.47

Charlottes Web Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -103.21 -139.77 -192.52 -1,267.81 0.00

CWBHF vs ZTS, UTHR: ROE % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Charlottes Web Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charlottes Web Holdings ROE % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Charlottes Web Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Charlottes Web Holdings's ROE % falls into.


CWBHF
32GF Score
Charlottes Web Holdings Inc CWBHF
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charlottes Web Holdings ROE % Calculation

Charlottes Web Holdings's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-29.741/( (27.087+-2.039)/ 2 )
=-29.741/12.524
=-237.47 %

Charlottes Web Holdings's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-52.448/( (-2.039+-15.041)/ 2 )
=-52.448/-8.54
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
Charlottes Web Holdings (CWBHF) has a ROE % of 0.00% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Charlottes Web Holdings and its competitors. According to the industry distribution chart, Charlottes Web Holdings ranks #930 out of 935 companies in the Drug Manufacturers industry, placing it in the top 99.5%.
Is Charlottes Web Holdings' ROE % too high?
Charlottes Web Holdings' current ROE % is 0.00%. Based on the distribution chart, Charlottes Web Holdings ranks #930 out of 935 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Charlottes Web Holdings has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Charlottes Web Holdings' ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Charlottes Web Holdings ranks #930 out of 935 companies for ROE %. This places Charlottes Web Holdings in the lower half of its industry. The industry median ROE % is 6.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.00, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Charlottes Web Holdings and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charlottes Web Holdings's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charlottes Web Holdings stock overvalued right now?
Based on GuruFocus' analysis, Charlottes Web Holdings (CWBHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.13, compared to a current price of $0.33 — trading 151.5% above its estimated fair value. The current ROE % is 0.00%. Charlottes Web Holdings' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Charlottes Web Holdings (CWBHF), the current ROE % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charlottes Web Holdings (CWBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Charlottes Web Holdings stock appears to be overvalued. The current stock price of $0.33 is trading 151.5% above its estimated GF Value™ of $0.13. GuruFocus considers Charlottes Web Holdings to be Significantly Overvalued.

Key valuation signals for CWBHF:

  • ROE %: 0.00%
  • GF Value™: $0.13 vs. price of $0.33 (151.5% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the CWBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charlottes Web Holdings Business Description

Other Exchanges 6CW:GermanyCWEB:Canada
Address 700 Tech Court, Louisville, CO, USA, 80027
Charlottes Web Holdings Inc is engaged in the production and distribution of hemp-based cannabidiol (CBD) wellness products. Its product categories include ingestible products (tinctures, capsules, and gummies), topicals, and pet products. The company distributes its products through an e-commerce website, third-party e-commerce websites, select distributors, health practitioners, and a variety of brick-and-mortar specialty retailers.
32GF Score

Get the complete analysis for CWBHF

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.33
Price
$0.13
GF Value